Doximity, Inc.
General ticker "DOCS" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $11.5B (TTM average)
Doximity, Inc. follows the US Stock Market performance with the rate: 37.5%.
Estimated limits based on current volatility of 1.3%: low 50.91$, high 52.21$
Factors to consider:
- Total employees count: 827 (-15.4%) as of 2024
- Top business risk factors: Strategic risks and growth management, Customer retention, Operational and conduct risks, Market competition, Reputation and brand risks
- Price in estimated range
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [48.32$, 80.19$]
- 2026-03-31 to 2027-03-31 estimated range: [44.14$, 74.76$]
Financial Metrics affecting the DOCS estimates:
- Negative: with PPE of 44.0 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 39.94 > 18.64
- Positive: Inventory ratio change, % of 0.56 <= 0.84
- Positive: Return on assets ratio (scaled to [-100,100]) of 15.00 > 6.04
- Negative: negative Industry operating cash flow (median)
- Negative: Operating cash flow per share per price, % of 2.36 <= 6.82
Short-term DOCS quotes
Long-term DOCS plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $419.05MM | $475.42MM | $570.40MM |
| Operating Expenses | $293.94MM | $311.54MM | $342.60MM |
| Operating Income | $125.11MM | $163.88MM | $227.80MM |
| Non-Operating Income | $8.05MM | $21.32MM | $35.77MM |
| R&D Expense | $80.19MM | $81.98MM | $93.04MM |
| Income(Loss) | $133.16MM | $185.20MM | $263.57MM |
| Taxes | $20.34MM | $37.62MM | $40.39MM |
| Profit(Loss)* | $112.82MM | $147.58MM | $223.19MM |
| Stockholders Equity | $966.12MM | $901.40MM | $1,082.62MM |
| Assets | $1,136.89MM | $1,079.37MM | $1,264.31MM |
| Operating Cash Flow | $179.60MM | $184.10MM | $273.26MM |
| Capital expenditure | $6.18MM | $5.80MM | $6.53MM |
| Investing Cash Flow | $-59.92MM | $31.19MM | $-29.30MM |
| Financing Cash Flow | $-74.46MM | $-276.52MM | $-131.14MM |
| Earnings Per Share** | $0.58 | $0.78 | $1.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.